Table 3.
Immune factors | Growth point (day) | Treatments | |||
---|---|---|---|---|---|
Control | L | M | H | ||
IL-2 | 14 | 0.40 ± 0.14 | 0.45 ± 0.12 | 0.49 ± 0.11 | 0.46 ± 0.09 |
28 | 0.34 ± 0.08b | 0.32 ± 0.06b | 0.62 ± 0.18a | 0.58 ± 0.07a | |
42 | 0.48 ± 0.14b | 0.39 ± 0.13b | 0.71 ± 0.07a | 0.59 ± 0.08ab | |
IFN-γ | 14 | 2.54 ± 0.42b | 2.64 ± 0.24b | 3.32 ± 0.67a | 3.23 ± 0.08a |
28 | 2.08 ± 0.06b | 2.22 ± 0.52ab | 3.14 ± 0.13a | 2.89 ± 0.28a | |
42 | 1.08 ± 0.23 | 1.19 ± 0.17 | 1.26 ± 0.33 | 1.16 ± 0.15 |
a–cValues in the same row without the same uppercase differed significantly (P < 0.05).